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OBJECTIVE: This study analyzed the frequency of cardiometabolic risk markers and metabolic syndrome
occurrence in overweight and obese children and adolescents.
METHODS: The participants included 161 overweight (n=65) and obese (n=96) individuals aged between 5 and
19 years. Clinical markers were assessed (body mass index, body fat percentage, waist circumference, acanthosis,
systolic and diastolic blood pressures, laboratory parameters [glucose, insulin, cholesterol (total and fractions)
and triglyceride levels and homeostasis model assessment of insulin resistance (HOMA-IR) index] and leptin and
adiponectin levels). The frequency of changes, odds ratios and correlations among markers were determined.
Metabolic syndrome was assessed according to International Diabetes Federation criteria.
RESULTS: A high frequency of acanthosis (51.6%); increased waist circumference (45.4%), systolic blood pressure /
diastolic blood pressure (8.1% / 9.3%), glucose (10%), insulin (36.9%) and HOMA-IR (44.3%) values; and
reduced high-density lipoprotein levels (47.2%) were observed. Leptin levels were increased in 95% of obese
and in 66% of overweight subjects. Adiponectin was decreased in 29.5% of obese and in 34% of overweight
subjects. An odd ratio analysis revealed a greater probability of increased waist circumference (9.0), systolic
blood pressure (4.1), triglyceride (2.3) and insulin (2.9) levels and HOMA-IR (3.0) in the obese group than in the
overweight group. The clinical and laboratory parameters and leptin levels exhibited significant correlations,
whereas adiponectin was negatively correlated with systolic blood pressure. The occurrence rate of metabolic
syndrome was 13.6%.
CONCLUSIONS: The high frequency of changes in clinical, laboratory and adipokine markers indicates the need
for early interventions aimed at preventing cardiometabolic complications in adulthood.
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’ INTRODUCTION
Childhood obesity is widely distributed in developed and
developing countries, and the prevalence of excess body
weight has increased progressively in the past 30 years, thus
becoming an important public health problem worldwide
(1). According to data from the World Obesity Federation,
29.5% of all female and 29.7% of all male children and
adolescents exhibited excess body weight, including obesity, in
the United States between 2013 and 2014 (2). In Brazil, data
from the Family Budget Surveys (Pesquisa de Orc¸amentos
Familiares – POF) from 2008 to 2009 show that 33.5% of
children between 5 and 9 years of age and 20.5% of adolescents
aged 10 to 19 years exhibited excess body weight, among
whom 14.3% and 4.9% were classified as obese, respectively
(3). The Southeast region of Brazil exhibited the highest
assessments of excess body weight, namely, 39% in children
and 22.6% in adolescents (3).
Obesity in childhood and adolescence is associated with a
series of comorbidities, including dyslipidemia, systemic
hypertension and changes in glucose metabolism, which in
concert with abdominal obesity, define metabolic syndrome.
The persistence of obesity is an important risk factor for the
development of type 2 diabetes mellitus (DM) and cardio-
vascular disease (CVD) in adults (1,4,5).DOI: 10.6061/clinics/2017(01)07
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Insulin resistance is an important condition that is
associated with overweight and obesity, and studies have
indicated that affected individuals exhibit a higher predis-
position for the development of metabolic disorders in
adulthood (1,6). An excess of body fat not only results in
metabolic changes in adipose tissue and the induction of
insulin resistance but also leads to endothelial dysfunction
via pro-inflammatory and pro-thrombotic effects due to the
action of pro-inflammatory cytokines and adipokines (7).
Leptin and adiponectin, which are the primary adipokines
produced by adipose tissue, play important roles in the
cardiometabolic outcomes associated with excess body
weight (7,8).
In Brazil, studies assessing cardiometabolic risk markers in
overweight children and adolescents show high frequencies of
changes in waist circumference (WC), blood pressure, dyslipi-
demia, insulin resistance and adipokine levels (6, 9,10,11).
The search for effective measures to identify obese
pediatric patients at a higher risk of developing metabolic
and cardiovascular complications constitutes a promising
strategy in the prevention of the comorbidities of early
obesity (6). Therefore, the objective of the present study was
to analyze the family history of excess body weight as well as
the clinical, laboratory and adipokine markers of cardiome-
tabolic risk and the occurrence of metabolic syndrome in
overweight and obese children and adolescents recruited
from public schools in a population study in the city of
Uberaba, Minas Gerais, Southeast Brazil.
’ MATERIALS AND METHODS
The present work is a descriptive and analytical prospec-
tive cross-sectional study that considered a population of 364
overweight and obese children and adolescents (5 to 19 years
of age) from public schools of the Municipality of Uberaba,
Minas Gerais, Brazil, who had participated in a previous
study on the prevalence of overweight status and obesity
(12). A total of 161 children and adolescents agreed to
participate in the study.
To achieve the proposed objectives, the clinical history of
the respective parents, such as the presence of excess body
weight, DM, hypertension and dyslipidemia, was obtained
by means of an inquiry.
Clinical Markers
Clinical markers were determined by assessing the
nutritional status of the subjects, which included weight,
height, skinfolds and WC, and by calculating the body mass
index (BMI) using standardized procedures (13,14). Accord-
ing to the criteria proposed by the World Health Organiza-
tion (WHO, 2006) (13), the nutritional state of all the parti-
cipants was classified based on the BMI z-score (z-BMI),
which was calculated with WHO-Anthro Plus 2007 soft-
ware, Geneva, Switzerland. Individuals were categorized
as overweight (+1p z-BMIo+2) or obese (z-BMIX+2).
The body fat percentage (BFP) was calculated using the sum
of four skinfolds as the criterion as in the equations of
Slaughter et al. (14), who measured triceps and subscapular
skinfold thicknesses. WC was measured while the individual
was in a standing position, midway between the lowest rib
and the top of the iliac crest, at the end of a normal
expiration, with a non-extensible tape measure with milli-
meter graduations. WC was considered high when the value
was within or above the 90th percentile (P90) according to sex
and age (15). Physical examinations also included a detailed
evaluation of the skin with respect to clinical signs of insulin
resistance, manifested by the presence of acanthosis nigri-
cans, which was assessed visually in the neck, armpits and
groin.
Systolic and diastolic blood pressures (SBP and DBP,
respectively) were measured in the right arm, and the
obtained values were classified according to sex, age and
height following the criteria of the I Guideline for Preventing
Atherosclerosis in Childhood and Adolescence (I Diretriz de
Prevenc¸ão da Aterosclerose na Infância e Adolescência) of
the Brazilian Society of Cardiology (16).
The pubertal stage was evaluated by a single researcher
and classified into pre-pubertal and pubertal, according to
the criteria of Marshall and Tanner (17,18).
Laboratory and Adipokine markers
Blood samples were collected after 10 h to 12 h of fasting
via peripheral venipuncture to assess the levels of fasting
glucose, insulin, total cholesterol, high- and low-density
lipoprotein cholesterol (HDL-C and LDL-C, respectively),
triglycerides (TGs), leptin and adiponectin. Specifically, serum
levels of total cholesterol, HDL-C and TG were assessed by an
enzymatic colorimetric assay, and fasting glucose levels were
determined by a hexokinase enzymatic assay. All samples were
processed in a COBAS 6000-analyzer module C501 (Roche-
Hitachi). Serum LDL-C levels were calculated with the
equation of Friedewald et al. (19). Insulin levels were measured
by electrochemiluminescence (ECL) (COBAS 6000 analyzer,
module C601, Roche-Hitachi). Finally, leptin levels were
measured in duplicate by an enzyme-linked immunosorbent
assay (ELISA) using a commercial kit from EMD Millipore,
Millipore Corporation (Billerica, MA, USA), with reference
values considered as a BMI of 18 to 25 kg/m2, i.e., 3.70 to
11.1 ng/mL for women and 2.0 to 5.6 ng/mL for men.
Adiponectin levels were measured by an ELISA, employing a
commercial kit provided by Abcam Inc. (Cambridge, USA) and
expressed as ng/mL.
Metabolic changes were considered according to the I
Guideline for Preventing Atherosclerosis in Childhood and
Adolescence (16).
The homeostasis model assessment of insulin resistance
(HOMA-IR) index was calculated by multiplying fasting
plasma insulin (mU/mL) by fasting glucose (mmol/L),
divided by 22.5. The cutoff point was X2.5 for pre-pubertal
(20) and X3.43 for pubertal individuals of both sexes (21).
The TG/HDL-C ratio (TG/HDL-C) was calculated by
dividing the serum TG level by the serum HDL-C level.
Characterization of metabolic syndrome
Metabolic syndrome was characterized according to the
criteria proposed by the International Diabetes Federation
(IDF) (22). Regarding the age rangeo10 years, the criteria of
the IDF were adapted, i.e., metabolic syndrome was consi-
dered as a WCXP90 associated with two of the following
criteria: fasting glucose X100 mg/dL, TGX130 mg/dL,
HDL-Co45 mg/dL and SBP or DBPXP95, according to sex,
age and height.
Statiscal Analysis
The data were subjected to a descriptive analysis based on
absolute and percent frequencies and measures of centrality
and dispersion.
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The Kolmogorov-Smirnov test was used to analyze the
normal distribution of numeric variables, and the homo-
geneity of variances between the groups was assessed with
Levene’s test.
In comparisons between two independent groups,
Student’s t-test was used for data with a normal distribution
and homogeneity of variances, and the Mann-Whitney U test
was used for data that did not meet the aforementioned
criteria.
Categorical variables were compared using the Chi-
squared (w2) test, and the odds ratio (OR) was calculated to
evaluate the probability of a specific event occurring over
another.
Correlations were analyzed with Pearson’s or Spearman’s
tests, and multiple linear regression was used for the
dependent variables leptin and adiponectin with clinical
and laboratory parameters as the predictor variables.
The level of significance was set at 5%. Statistical analyses
were performed with the software STATISTICA, Statsoft
version 10 and R.
Ethical Aspects
The present study was approved by the Human Research
Ethics Committee of the Federal University of Triângulo
Mineiro (Universidade Federal do Triângulo Mineiro), under
the number 2479, and all parents/legal guardians signed the
informed consent form.
’ RESULTS
Regarding the nutritional assessment of the studied
population, 40.4% (65/161) were overweight, and 59.6%
(96/161) were obese children and adolescents. Among the
parents, 65.8% had excess body weight, 10.4% had DM,
32.5% had systemic arterial hypertension, and 19.5% had
dyslipidemia.
In the overweight group, the mean age was of 12.6±3.4
years; 70.8% (46/65) were female, and 73.8% (48/65) were
pubertal. In the obese group, the mean age was of 10.9±2.5
years; 59.4% (57/96) were female, and 51% (49/96) were
pubertal (Table 1). The overweight group had a significantly
higher mean age (p=0.0002) and predominance of pubertal
individuals (p=0.003) compared to the obese group. Further-
more, the obese group exhibited significantly higher BMI
(kg/m2), z-BMI, BFP and WC values than the overweight
group (po0.0001), while there was no statistically significant
difference between the groups in the mean SBP and DBP
measurements (Table 1).
The biochemical, hormone and adipokine profiles of the
overweight and obese groups are described in Table 1. The
obese group exhibited significantly higher serum total
cholesterol, LDL-C, TG, TG/HDL-C, insulin and HOMA-IR
values. Regarding adipokines, serum leptin levels were
significantly higher in the obese group and were above the
adopted reference values in 95% of the obese group and 66%
of the overweight group. Adiponectin was not detected in
the serum of all of the studied individuals, given that
concentrations were below the detection limit of the applied
method in 34% of the overweight group and 29.5% of the
obese group, with no statistically significant difference
between the groups (Table 1).
In the total sample (n=161), the WC was increased (XP90)
in 73 (45.4%) individuals, and the SBP and DBP were in-
creased (XP95) in 13 (8.1%) and 15 (9.3%) individuals, respec-
tively (Table 2).
Acanthosis nigricans was present in 51.6% of the total
sample (83/161) and was significantly higher in the obese
group (62/96, 64.6%) than in the overweight group (21/65,
32.3%) (po0.0001; Table 2). The obese group also exhibited a
significantly higher percentage of cervical (61.5% versus
18.5%) and axillary acanthosis (46.9% versus 21.5%) than the
overweight group (Table 2).
Table 1 - Clinical and laboratory characterization of overweight and obese children and adolescents recruited from the public schools







Age (years) # 12.6±3.4 10.9±2.5 0.0002
Sex (M/F) f 19/46 39/57 0.13
Pubertal stage (pre-pubertal/pubertal) f 17/48 47/49 0.003
BMI (kg/m2) # 23.0±3.1 27.1±3.7 o0.0001
BMI z-score ¤ 1.6 (1.0-2.0) 2.57 (2.0-4.9) o0.0001
Waist circumference (cm) # 73.4±8.4 84.0±10.7 o0.0001
Body fat percentage # 34.5±9.0 43.1±8.4 o0.0001
Systolic blood pressure (mmHg) # 106.4±9.7 108.7±10.0 0.15
Diastolic blood pressure (mmHg) # 68.6±7.6 70.3±7.9 0.19
Total cholesterol (mg/dL) # 159.0±33.5 169.9±32.5 0.04
HDL-cholesterol (mg/dL) # 46.7±10.8 44.6±11.2 0.23
LDL-cholesterol (mg/dL) # 94.6±29.6 105.5±30.3 0.03
Triglycerides (mg/dL) ¤ 81.0 (38.0-196.0) 91.0 (31.0-445.0) 0.04
TG/HDL¤ 1.76 (0.6-5.8) 2.1 (0.6-10.3) 0.04
Glucose (mg/dL) # 85.4±12.1 87.6±11.5 0.230
Insulin (mIU/mL) ¤ 11.6 (3.5-32.8) 14.5 (1.4-117.2) o0.0001
HOMA-IR ¤ 2.3 (0.7-7.1) 3.2 (0.3-28.7) o0.0001
Leptin (ng/mL) # 15.2±9.4 24.1±11.4 o0.0001
Adiponectin (ng/mL) ¤ 6.5 (0.0-96.0) 6.5 (0.0-43.2) 0.8
Source: the author
# t-test, values are expressed as the means ± standard deviation;
fChi-squared test;
¤Mann-Whitney test, values are expressed as medians (Vmin-Vmax).
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According to the OR analysis, the probability of increased
WC was 9.0 times higher (4.1-19.4) in the obese group than in
the overweight group, while the probability of increased SBP
was 4.1 times higher (0.9-19.0) and that of the presence of
acanthosis nigricans was 3.8 (2.0-7.4) times higher in the
obese group (Table 2).
Changes in the laboratory parameters with respect to the
reference data ranged from 10.0% (regarding glucose) up to
47.2% (regarding HDL-C) of the studied population. There
was a significantly higher ratio of obese children and
adolescents with changes in TG (29.2%; p=0.04), insulin
(46.3%; p=0.002) and HOMA-IR index (54.7 %; p=0.001)
(Table 3).
The OR analysis revealed a 2.3 (1.0-5.0) times greater
probability of exhibiting increased levels of serum TG, a 2.9
(1.4-5.8) times greater probability of increased insulin levels
and a 3.0 (1.5-5.9) times greater probability for altered
HOMA-IR values in the obese group compared with the
overweight group (Table 3).
The simple linear correlation coefficients between the
clinical, laboratory and adipokine parameters are presented
in Table 4. All the parameters were significantly correlated
with leptin, whereas adiponectin only exhibited a significant
negative correlation with SBP. Based on these significant
correlations, a multiple linear regression model was applied
and adjusted for age, sex, pubertal staging, BMI, z-BMI, WC,
BFP, SBP, DBP, HDL-C, TG, glucose, insulin and HOMA-IR
value, considering leptin as the dependent variable. In this
model, sex (po0.0001), WC (p=0.004), BFP (p=0.009) and
pubertal stage (p=0.04) explained 63% of the changes in the
serum leptin levels (r2=0.63; leptin = -6711+ 8.39 sex+0.38
WC + 0.27 BFP – 3.92 pubertal stage). The same multiple
linear regression analysis was performed with SBP as the
predictor and adiponectin as the dependent variable;
however, SBP exhibited no statistical significance.
In the analysis of the clinical and laboratory data, the
occurrence rate of metabolic syndrome, as defined according
to the adopted criteria, was 13.6% (22/161), among which
there was one overweight and 21 obese individuals and
10 children under 10 years of age. Of note, children with and
without metabolic syndrome exhibited similarities regarding
sex, age and pubertal stage. Furthermore, all parameters in
the clinical and metabolic profiles of the individuals with
metabolic syndrome were significantly increased, except for
LDL-C and glucose, which exhibited no statistically sig-
nificant difference (Table 5).
The analysis according to the number of criteria used
to characterize metabolic syndrome revealed that 32.3%
(52/161) of the participants presented with none of the criteria,
whereas 30.4% (49/161) presented with one criterion, 23.6%
(38/161) presented with two, 11.2% (18/161) presented with
three, and 2.5% (4/161) presented with four of the criteria for
metabolic syndrome.
’ DISCUSSION
In view of the growing body of studies on the risk factors
for CVD and type 2 DM, the failure to identify and act upon
Table 2 - Percentage of clinical changes in overweight and obese children and adolescents recruited from the public schools of the
Municipality of Uberaba, Minas Gerais State, Brazil, from February 2013 to July 2014.
Group (%)
General Overweight Obese
Changes (n=161) (n=65) (n=96) p-value OR (95% CI)
Waist circumference y 45.3 17.0 64.6 o0.0001 9.0 (4.1-19.4)
Systolic blood pressure y 8.1 3.1 11.4 0.05 4.1 (0.9-19.0)
Diastolic blood pressure y 9.3 6.1 11.4 0.25 1.9 (0.6-6.5)
Acanthosis nigricans w 51.6 32.3 64.6 o0.0001 3.8 (2.0-7.4)
Cervical acanthosis nigricans w 44.1 18.5 61.5 o0.0001 7.0 (3.3-14.9)
Axillary acanthosis nigricans w 36.6 21.5 46.9 0.001 3.2 (1.6-6.6)
Source: the author
y Increased; w Present;
OR: odds ratio; 95% CI: 95% confidence interval.
Table 3 - Percentage of laboratory changes in overweight and obese children and adolescents recruited from the public schools of the
Municipality of Uberaba, Minas Gerais State, Brazil, from February 2013 to July 2014.
Group (%)
General Overweight Obese
Changes (n=61) (n=65) (n=96) p-value OR (95% CI)
Total cholesterol y 40.4 32.3 45.8 0.08 1.8 (0.9-3.4)
HDL-cholesterol f 47.2 39.7 52.1 0.12 1.6 (0.9-3.1)
LDL-cholesterol y 16.5 12.7 18.9 0.29 1.6 (0.6-3.9)
Triglycerides y 23.6 15.4 29.2 0.04 2.3 (1.0-5.0)
Glucose y 10.0 9.4 10.4 0.82 1.1 (0.4-3.3)
Insulin y 36.9 23.1 46.3 0.002 2.9 (1.4-5.8)




OR: odds ratio; 95% CI: 95% confidence interval.
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these risk factors in childhood and adolescence entails the
sustainment of the above pathologies into adulthood, thus
increasing the probability of adverse outcomes.
In the present study, we found a high frequency (65.8%) of
excess body weight reported by parents, and studies indicate
that the presence of obesity in parents seems to be an
important risk factor for the development of early obesity in
childhood, resulting from the sum of genetic influences and
the influence of the parent’s lifestyle on their children (23). In
addition to obesity, a family history of DM, hypertension,
dyslipidemia and early atherosclerotic disease are risk factors
for CVD and DM in offspring (1,23).
Considering that the probability of permanent obesity in
adulthood is 20% to 50% in cases when obesity occurs before
sexual maturity and 50% to 70% in cases in which obesity
occurs after the onset of puberty, the nutritional assessment
of obese children and adolescents should clearly take into
account chronological age and degree of sexual maturity (6).
We found obesity in underage children and adolescents in
equal proportions with regard to sexual maturity (49% of the
Table 4 - Simple linear correlation (r) between clinical, laboratory and leptin parameters in overweight and obese children and




Variable r p r p r p
BMI # 0.89 0.001 0.69 0.001
BMI z-score ¤ 0.64 0.001 0.54 0.0001 0.47 0.0001
Waist circumference # 0.89 0.001 0.68 0.0001
Body fat percentage # 0.70 0.001 0.71 0.001 0.60 0.0001
Systolic blood pressure # 0.53 o0.0001 0.53 o0.0001 0.36 o0.0001
Diastolic blood pressure # 0.43 0.0001 0.43 0.001 0.29 0.0001
Total cholesterol # 0.09 NS 0.16 0.04 0.09 NS
HDL-cholesterol # -0.20 0.01 -0.20 0.006 -0.10 NS
LDL-cholesterol # 0.13 NS 0.18 0.03 0.08 NS
Triglycerides ¤ 0.20 0.01 0.23 0.003 0.20 0.014
TG/HDL-C ¤ 0.24 0.003 0.28 0.0003 0.21 0.009
Glucose # 0.12 NS 0.14 NS 0.13 NS
Insulin ¤ 0.52 o0.0001 0.50 o0.0001 0.39 o0.0001
HOMA-IR ¤ 0.54 o0.0001 0.52 o0.0001 0.40 0.0001
Leptin # 0.69 0.001 0.68 0.0001
Source: the author
# Pearson´s linear correlation coefficient
¤ Spearman´s linear correlation coefficient
NS: non-significant
Table 5 - Clinical and laboratory characterization of individuals with and without metabolic syndrome.
METABOLIC SYNDROME
Variable NO (n=139) YES (n=22) p-value
Age (years) # 11.4±3.1 11.3±2.8 0.70




BMI (kg/m2) # 24.9±3.9 29.1±2.9 o0.0001
BMI z-score # 2.1±0.7 3.1±0.8 o0.0001
Waist circumference (cm) # 78.0±10.6 89.9±8.8 o0.0001
Body fat percentage # 37.9±8.6 50.9±8.0 o0.0001
Systolic blood pressure (mmHg) # 106.6±9.2 115.3±11.5 0.0001
Diastolic blood pressure (mmHg) # 68.4±7.2 77.6±6.9 o0.0001
Total cholesterol (mg/dL) # 163.4±32.9 179.0±33.2 0.04
HDL-cholesterol (mg/dL) # 46.9±10.6 36.6±9.7 o0.0001
LDL-cholesterol (mg/dL) # 99.4±30.3 112.1±29.3 0.07
Triglycerides (mg/dL) # 92.7±48.4 151.6±53.5 o0.0001
TG/HDL ¤ 1.7 (0.6-10.4) 3.9 (2.0-9.9) o0.0001
Glucose (mg/dL) # 86.2±11.7 90.1±11.7 0.15
Insulin (mIU/mL) ¤ 12.4 (2.9-42.9) 20.6 (1.4-117.2) 0.0002
HOMA-IR ¤ 2.5 (0.5-11.6) 4.3 (0.3-28.7) 0.0002
Leptin (ng/mL) # 19.3±11.1 28.7±10.8 0.0003
Adiponectin (ng/mL) # 10.7±15.1 10.1±12.1 0.86
Source: the author
# t-test, values are expressed as the means ± standard deviation;
fChi-squared test;
¤Mann-Whitney test, values are expressed as medians (Vmin-Vmax).
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pre-pubertal and 51% of the pubertal individuals). Notably,
these are alarming data, and early intervention is required to
avoid the comorbidities associated with obesity.
In the analysis of the studied population, we found a high
frequency of increased WC (45.4%), which was more predo-
minant in the obese group; this group also exhibited a higher
BFP (total adiposity). These findings corroborate other
Brazilian studies showing that increased BMI and body
adiposity, particularly central adiposity, potentiate the
emergence of metabolic risk factors (6,9,24). In a study of
obese adolescents in São Paulo state, Brazil, Masquio et al.
(10) found that WC is positively correlated with the number
of metabolic syndrome parameters, inflammatory biomar-
kers and visceral fat and is a simple and practical method to
assess visceral adiposity. Furthermore, data from the
Bogalusa Heart study (25) show a high cardiometabolic risk
for children with abdominal obesity and excess or normal
body weight compared to children with excess body weight
devoid of excess abdominal fat. In the present study, the
obese group had a nine-fold greater probability of exhibiting
an increased WC compared with the overweight group, thus
rendering WC an important practical clinical measure to
estimate cardiometabolic risk.
In a study of Brazilian adolescents ranging in age from
10 to 16 years, Moser et al. (26) have shown that triceps skin-
fold thickness and BMI represent anthropometric indicators
independently associated with blood pressure above P90,
irrespective of abdominal adiposity and sexual maturity.
Furthermore, a high BMI increased the risk of high blood
pressure nearly three-fold among students with excess body
weight compared with eutrophic controls. Morrison et al. (5)
have shown that maintaining a normal BMI from childhood
up to adulthood is a significant negative risk factor for CVD
in adulthood and also that high blood pressure throughout
childhood up to adulthood increases the probability of
exhibiting type 2 DM. In the present study, two groups with
altered BMI values were compared, and the mean blood
pressure did not differ between the groups. However, the
obese group exhibited a 4 times greater probability of
increased blood pressure than the overweight group. In
addition, we found a positive correlation between BMI, WC
and blood pressure, thus reinforcing the classification of BMI
and WC as anthropometric markers of cardiovascular risk.
Studies indicate that the process of atherosclerosis begins
in childhood and is related to obesity and cardiovascular risk
factors, such as hypertension, dyslipidemias and changes in
glucose metabolism (10,11,27). In adolescents, carotid intima-
media thickness, which is considered a subclinical marker of
atherosclerosis, has been found to be positively correlated
with parameters of metabolic syndrome, including LDL-C,
low HDL-C, TG, subcutaneous abdominal fat volume,
visceral fat volume and blood pressure (27,28). In the present
study, changes in lipid metabolism were highly relevant, and
the obese group exhibited higher means of total cholesterol,
LDL-C, TG and TG/HDL-C compared with the overweight
group. In the Princeton Lipid Research Clinics (LRC) follow-
up study, Morrison et al. (5) showed that individuals with
high TG levels from childhood up to adulthood exhibited
an increase in cardiovascular events during adulthood.
This result reveals the importance of early diagnosis and
treatment of metabolic changes. In support of this approach,
other follow-up studies have shown that overweight and
obese children who became non-obese adults normali-
zed the risks of dyslipidemia, hypertension and subclinical
atherosclerosis in adulthood, thus behaving like individuals
who had never been obese (29).
An increase in adipose tissue during childhood is likely an
initial event in the development of alterations in glucose
metabolism and represents a trigger for insulin resistance.
Therefore, the search for clinical and laboratory indicators of
insulin resistance in obese children is necessary (20). We
found a high prevalence of acanthosis nigricans, a clinical
marker of insulin resistance, and changes in glycemia, fasting
insulinemia and the HOMAR-IR index values in the studied
population, as previously reported in other studies of
Brazilian children and adolescents (6,10,11). These changes
were predominant in the obese group, except for fasting
glycemia, which exhibited similar changes in both groups.
The Bogalusa Heart study (30), a longitudinal study, has
shown that individuals with persistently high insulin levels
also exhibit higher BMI, blood pressure and levels of total
cholesterol, LDL-C, TG and glucose and lower HDL-C levels
compared with individuals with lower insulin levels.
Furthermore, persistently high insulin levels over time were
associated with a higher probability of developing hyperten-
sion, dyslipidemia and obesity in young adults. In a cohort
study of white and black girls who had a diagnosis of
metabolic syndrome and insulin levels within the upper
quartile at 10 years of age, Morrisson et al. (31) found a high
percentage of evolution into altered fasting glucose and
type 2 DM 14 years later. This finding is in agreement with
another study on childhood cardiometabolic risk factors
and evolution into type 2 DM after 25 to 30 years (32).
A significant positive association has also been found
between BMI and insulin, HOMA-IR values and BMI,
HOMA-IR values and WC as well as HOMA-IR values
and TG among children and adolescents (6,33), thus further
corroborating the results of the present study, which show a
three-fold greater probability of obesity associated with
increased insulin levels and HOMA-IR values.
Adipokines secreted by visceral adipose tissue are asso-
ciated with components of metabolic syndrome (4,7,10).
Studies on obese children, adolescents and adults have
evidenced a direct correlation between leptin and adiposity
markers (BMI, WC and BFP) and with glucose, insulin and
HOMA-IR values (8,9,34). Additionally, studies on adipo-
nectin have shown an inverse correlation with BMI, WC,
insulin, HOMA-IR and TG values (8,35). In the present study,
we found a positive correlation between leptin and adiposity
markers, blood pressure, insulin and HOMA-IR values.
Adiponectin was not significantly correlated with adiposity
markers; however, several samples were below the detection
limits of the method, and we suggest the presence of
hypoadiponectinemia in these patients, which has already
been documented in the literature (8,9,35). Studies have also
shown that adiponectin levels decrease with age and are
higher in girls (8,9). In the present work, we suggest that
there was no difference between the groups, given that the
overweight children were older but were predominantly
female.
An increased prevalence of metabolic syndrome has
accompanied the global epidemic of obesity. This increase
has also occurred in the pediatric age range, and as
previously observed, components of metabolic syndrome
are already present at early ages. The definition of the criteria
for metabolic syndrome in children and adolescents is still
prone to limitations and difficulties with respect to the
uniformity of the criteria used for diagnosis. However,
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adaptations have been used in the literature (4,6,20). In the
present casuistic, we found a 13.6% occurrence rate of
metabolic syndrome, and even though the criteria of the IDF
are not applicable to children below 10 years of age, we
found a significant number of children who met these adap-
ted criteria. Thus, regardless of the definition of metabolic
syndrome, the high percentage of individuals with at least
one criterion indicates the need for early intervention
regarding the detected risk factors.
The risk factors identified among obese children and
adolescents tend to persist throughout adulthood if not
treated, thus contributing to an ever earlier establishment of
CVD. Therefore, the high percentage of clinical and meta-
bolic changes of cardiovascular risk found in the present
study on overweight and obese children and adolescents
indicates the need to develop local public health policies and
to establish measures involving changes in the habits and
lifestyle of this population.
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